This invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of formula (I) or a salt thereof:
wherein R1 is imidazolyl, pyridinyl or pyrimidinyl, any of which is optionally substituted by one group independently selected from C1-3alkyl and C1-3alkoxy.
本发明涉及一种通过公式(I)的化合物或其盐来调节α7
尼古丁酰
胆碱受体(nAChR),其中R1是
咪唑基、
吡啶基或
嘧啶基之一,其中任何一个都可以选用从C1-3烷基和C1-3烷氧基中独立选择的一种基团进行取代。